Skip to main content
VITAL KSK HOLDINGS,INC. logo

VITAL KSK HOLDINGS,INC. — Investor Relations & Filings

Ticker · 3151 ISIN · JP3778280002 LEI · 353800RLGNMAZY8D4488 T Wholesale and retail trade
Open in API
Filings indexed 80 across all filing types
Latest filing 2025-11-27 Regulatory Filings
Country JP Japan
Listing T 3151

About VITAL KSK HOLDINGS,INC.

https://www.vitalksk.co.jp/english/

VITAL KSK HOLDINGS, INC. is a holding company primarily engaged in the pharmaceutical wholesale business. The company distributes a wide range of pharmaceuticals to medical institutions, including hospitals and clinics. In addition to its core wholesale operations, the group's business activities extend to related sectors such as the operation of pharmacies and the distribution of veterinary drugs. Leveraging its extensive local networks, the company collaborates with a broad spectrum of healthcare providers, including municipalities and long-term care facilities, to offer support and solutions for regional healthcare challenges.

Recent filings

Filing Released Lang Actions
訂正臨時報告書
Regulatory Filings Classification · 100% confidence The document is a 'Rinji Hokokusho' (Extraordinary Report) filed with the Kanto Local Finance Bureau in Japan. It specifically states it is a 'Correction Report' (Teisei Hokokusho) for a previously filed Extraordinary Report regarding the sale of investment securities and the resulting impact on financial results (extraordinary profit and non-operating income). Since this is a regulatory filing regarding specific corporate events (asset sales/financial impact) that does not fit into the other specific categories like 10-K or M&A, it falls under the general regulatory filing category.
2025-11-27 Japanese
確認書
Regulatory Filings Classification · 100% confidence The document is a 'Confirmation Letter' (確認書) filed under the Financial Instruments and Exchange Act. It serves as an officer certification regarding the accuracy of a semi-annual report. According to the 'CERTIFICATION RULE', documents that are primarily officer certifications or attestations should be classified as Regulatory Filings (RNS), even if they reference a specific report type like an interim/semi-annual report. H1 2025
2025-11-14 Japanese
半期報告書－第17期(2025/04/01－2026/03/31)
Interim / Quarterly Report Classification · 100% confidence The document is a '半期報告書' (Semi-Annual Report) filed under the Financial Instruments and Exchange Act of Japan. It contains comprehensive financial statements, including the balance sheet, for the interim period (2025-04-01 to 2025-09-30). It includes detailed management analysis, segment information, and audit review information. This fits the definition of an Interim/Quarterly Report (IR). H1 2026
2025-11-14 Japanese
確認書
Audit Report / Information Classification · 98% confidence The document is extremely short (601 characters) and contains a header section typical of Japanese regulatory filings, specifically mentioning a '確認書' (Confirmation Document) submitted to the '関東財務局長' (Kanto Local Finance Bureau Director) based on Article 24-4-2, Paragraph 4 of the Financial Instruments and Exchange Act. The core content confirms that the President/CEO has verified the appropriateness of the contents of the '有価証券報告書' (Securities Report/Annual Report) for the fiscal year ending March 31, 2025. This document is a certification or confirmation related to a previously filed annual report (likely a 10-K equivalent in Japan, which is the Yuho). Since this is a short confirmation document related to the accuracy of a major filing, and not the full report itself, it fits best under the general 'Regulatory Filings' category (RNS) or potentially an Audit Report (AR) if it were an auditor's confirmation. However, given it is a management certification confirming the accuracy of the *Securities Report* (which is the Japanese equivalent of a 10-K), and it is a standalone, short confirmation document, RNS is the most appropriate general regulatory fallback, as AR is usually reserved for standalone audit reports or stress tests, and 10-K is the full annual report. Given the context of confirming the accuracy of a major filing, RNS (Regulatory Filings) is the safest general classification for this specific confirmation document. FY 2025
2025-07-09 Japanese
訂正有価証券報告書－第16期(2024/04/01－2025/03/31)
Annual Report Classification · 100% confidence The document is a Japanese 'Yukashoken Hokokusho' (Securities Report), which is the Japanese equivalent of a 10-K annual report. The header explicitly identifies it as a 'Securities Report' (有価証券報告書) filed under the Financial Instruments and Exchange Act, covering the fiscal year from April 1, 2024, to March 31, 2025. It contains extensive XBRL tagging and financial data, confirming it is the full annual report rather than a mere announcement. FY 2025
2025-07-09 Japanese
確認書
Audit Report / Information Classification · 95% confidence The document is extremely short (601 characters) and contains a table structure typical of Japanese regulatory filings, specifically mentioning '【提出書類】確認書' (Filing Document: Confirmation Document) and referencing the '金融商品取引法' (Financial Instruments and Exchange Act). The core content confirms that the President has verified the appropriateness of the contents of the '有価証券報告書 の訂正報告書' (Correction Report for the Annual Securities Report) for the fiscal year ending March 31, 2025. Since this document is a confirmation/verification statement about another primary filing (the Correction Report for the 10-K/Annual Securities Report) rather than the full report itself, and given its brief nature, it functions as a regulatory confirmation or supplementary filing. It does not fit perfectly into the main categories like 10-K (Annual Report) or IR (Interim Report). Given the nature of confirming the accuracy of a major filing, and lacking a specific code for 'Correction Report Confirmation,' the most appropriate general category for regulatory confirmations that don't fit elsewhere is 'Regulatory Filings' (RNS). However, since the document explicitly deals with the accuracy of the Annual Securities Report (which corresponds to 10-K), and this confirmation is a mandatory step, it is a specific regulatory filing. Given the options, RNS is the best fit for a miscellaneous regulatory confirmation document that isn't a primary report or a standard announcement like dividend or management change. FY 2025
2025-07-01 Japanese

Browse filings by year

11 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.